Shire buys into regenerative medicine with Pervasis purchase

Article Date: 13/04/2012 10:00
Shire buys into regenerative medicine with Pervasis purchase

Vacancy Search

Quick job search

Advanced Search

Latest News

NICE backs Soliris at £340K per patient per year

NICE backs Soliris at £340K per patient per year
more news